COMMUNIQUÉS West-GlobeNewswire

レコルダティ、エジャイモ®のグローバル権利取得に合意し、希少疾患事業を強化

04/10/2024 - 11:07

レコルダティ、エジャイモ®のグローバル権利取得に合意し、希少疾患事業を強化ミラノ、2024年10月4日 – レコルダティは本日、サノフィとエジャイモ®（スチムリマブ）のグローバル権利を取得する契約を締結したことを発表しました。エジャイモ®は、寒冷凝集素症（CAD: Cold Agglutinin Disease）という希少なB細胞リンパ増殖性疾患の治療において唯一承認された生物学的製剤です。エジャイモ®（スチムリマブ）は、 [...]

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE

04/10/2024 - 07:45

Milan, 4 th October 2024 – Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold [...]

Valneva SE - Declaration of shares and voting rights - September 30, 2024

04/10/2024 - 07:30

VALNEVA Declaration of shares and voting rights September 30, 2024 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard [...]

Valneva SE - Déclaration d’actions et de droits de vote - 30 septembre 2024

04/10/2024 - 07:30

VALNEVA Déclaration d’actions et de droits de vote 30 septembre 2024 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]

Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust

04/10/2024 - 00:00

Strengthens balance sheet with non-dilutive capital to enable further pipeline development and related strategic priorities CAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a [...]

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

03/10/2024 - 22:45

CINCINATTI, OH., Oct. 03, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Onconetix, Inc. (Nasdaq: ONCO), please note that in the first paragraph of the release, the name of the [...]

Ultragenyx Provides Update on Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease

03/10/2024 - 22:30

NOVATO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today reported that the Phase 1/2/3 Cyprus 2+ study of its UX701 gene therapy has demonstrated meaningful clinical activity [...]

AMN Healthcare Appoints Brian Scott as CFO and COO

03/10/2024 - 22:30

Seasoned Healthcare Executive Brings Robust Financial Strategy Experience, Including Previous Role as Chief Financial Officer and Chief Accounting Officer of AMN for More Than 10 Years DALLAS, Oct. 03, 2024 (GLOBE [...]

BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03/10/2024 - 22:15

MELVILLE, N.Y., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ), a regenerative medicine innovator focused on stem cell-based therapies and [...]

Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024

03/10/2024 - 22:05

CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will [...]

Helio Genomics Methylation Model Score for Early Cancer Detection Awarded as a Top Abstract for the 2024 San Antonio Liver Cancer Symposium

03/10/2024 - 22:05

IRVINE, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today [...]

IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03/10/2024 - 22:05

WINTER SPRINGS, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today [...]

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

03/10/2024 - 22:05

SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, [...]

Iridex Appoints Patrick Mercer as Chief Executive Officer

03/10/2024 - 22:05

MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03/10/2024 - 22:01

CAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease

03/10/2024 - 22:01

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease PARIS, France, October 3, 2024 – 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX; Nasdaq: ABVX [...]

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

03/10/2024 - 22:00

MARLBOROUGH, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), the Spatial Biology Company ® , today announced Scott Mendel has been appointed as Chairman of its Board, effective [...]

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/10/2024 - 22:00

SOUTH SAN FRANCISCO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 30, 2024 it granted stock options to purchase an aggregate of 88,653 shares of [...]

Direct Relief Makes $74 Million in Medical Aid Available to Communities Impacted by Hurricane Helene

03/10/2024 - 20:21

SANTA BARBARA, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- In the wake of Hurricane Helene’s devastating impact, Direct Relief has made available $74 million in medicines and medical supplies and $250,000 in financial [...]